Newsroom

Statement on the Biden Administration’s Final Regulations to Implement the No Surprises Act
08.19.2022
Statement from Laura and John Arnold on Landmark Law to Lower Prescription Drug Prices
08.16.2022
Statement from Laura and John Arnold Following Senate Passage of the Inflation Reduction Act of 2022
08.07.2022
“It’s time to finish the job.”: Statement from Mark E. Miller on Historic Opportunity for Congress to Lower Prescription Drug Prices
06.30.2022
Statement from Mark E. Miller on Medicare Advantage Oversight Hearing
06.27.2022
Statement from Mark E. Miller on New Insulin Legislation Offered in Senate
06.23.2022
Statement from Arnold Ventures’ Mark Miller on Federal Judge’s Ruling on Surprise Billing Arbitration Process
02.24.2022
Arnold Ventures’ Statement on the Removal of Drug Pricing from the Build Back Better Framework
10.28.2021
No Surprises Act Implementation Positive Sign for Patients Hurt By Surprise Bills
10.01.2021
Arnold Ventures’ Statement on Medicare Trustees Report
09.01.2021
Arnold Ventures’ Statement on No Surprises Act Final Rule
07.01.2021
Arnold Ventures’ Statement on the Elijah E. Cummings Lower Drug Costs Now Act
04.22.2021
A Statement from Arnold Ventures on Surprise Medical Billing Legislation
12.22.2020
A Statement From Arnold Ventures on Organ Donation Rules
12.21.2020
Arnold Ventures’ Statement on the Supreme Court Ruling on Trump v. Commonwealth of Pennsylvania
07.08.2020
Arnold Ventures Submits Public Comment on Proposed Organ Donation Rule
02.21.2020
John Arnold Statement on the Passage of HR 3, Lower Drug Costs Now Act of 2019
12.12.2019
Manatt and Arnold Ventures Release Opioid Toolkit for State Medicaid Leaders
11.12.2019
Arnold Ventures Announces National Program to Expand Opioid Treatment in Jails
05.09.2019
Introducing ​“Deep Dive with Laura Arnold,” an issues-based podcast from Arnold Ventures
04.30.2019
Arnold Ventures Statement on Energy and Commerce Committee Passage of Six Drug Pricing Bills
04.04.2019
Arnold Ventures’ Mark Miller Testifies Before Senate Committee on Finance
01.30.2019
Arnold Foundation Announces Funding for First-of-its-Kind Addiction Treatment Rating System
12.19.2018
Three Foundations Commit $30 Million to Civica Rx in Effort to Address Drug Shortages, High Prices
09.06.2018

Press Contact

Headshot of David Hebert
David Hebert

Press Kit

What are you looking for?

Grants

Arnold Ventures funds projects to understand problems and identify policy solutions.

See All Grants
Map of the U.S. made of Arnold Ventures icons
Our Work About News & Stories Contact Grants RFPs Careers Press Releases Employees Newsletter

Have an evidence-based week

Get The Abstract from Arnold Ventures delivered to your inbox.